While they have record profits. But that’s apparently a good reason to lay off people. Why share earnings with people who actually created value? It’s really about time large pharmaceutical companies are more closely looked into re: pricing in the US market, taxation and worker policies.
There are no replies in this thread yet. Be the first to post a reply below: